OpenAlex
PricingAboutJobs
Log inGet started
Work

The disconnect between phase II and phase III trials of drugs for heart failure

HTML

Year: 2013
Type: review
Source: Nature Reviews Cardiology
DOI: 10.1038/nrcardio.2012.181
Authors: Muthiah Vaduganathan, Stephen J. Greene, Andrew P. Ambrosy, Mihai Gheorghiade, Javed Butler
Institutions: Harvard University, Massachusetts General Hospital, Northwestern University, Stanford Medicine, Stanford University, Emory University
Language: English

Topic: Heart Failure Treatment and Management
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: heart failure, drug development, trial design, clinical trial endpoints, mortality, levosimendan, tezosentan, tolvaptan, nesiritide, target population selection, drug safety and efficacy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2071907783
FWCI: 2.138
Cites: 85
Cited by: 78
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms